← Leaderboards
Alice Chia- Chi Wei
Sloan-Kettering Inst Can Research
$2,617,533
Attributed
$2,617,533
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $683.1K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,617,533 · 1
By mechanism
P50$2,617,533 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- John Thomas Poirier$4,490,380
- Brian Matthew Zeglis$6,881,872
- Edwin Charles Pratt$687,237
- Simone Krebs$3,266,625
- Kenneth H. Yu$4,069,136
Others in their field
Other Rising Stars on “Design”
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Sabrina Paganoni · Massachusetts General Hospital$30,895,527
Research focus
DesignDetectionAbdomenCurative TreatmentsAdvanced Pancreatic CancerBiomarker DevelopmentAdjuvant ChemotherapyBloodBlood-Based BiomarkerBiologicalCa-19-9 AntigenBiological MarkersCandidate MarkerCapecitabineCessation Of LifeChemoradiationChemotherapyChemotherapy-Oncologic ProcedureClinicClinical TrialsBlood SpecimenComputer AnalysisCorrelative StudyDiagnosis
Grant awards (4)
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma$641,782
P50 · FY2025 · CA · contact PI
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma$647,018
P50 · FY2024 · CA · contact PI
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma$683,063
P50 · FY2023 · CA · contact PI
Total Neoadjuvant Therapy (TNT) for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma$645,670
P50 · FY2022 · CA · contact PI